Improving opioid effectiveness: From ideas to evidence

European Journal of Pain

Volumn 9, Issue 2 SPEC. ISS., 2005, Pages 131-135

  Kalso, Eija ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Gabapentin; N methyl D aspartate; Non steroidal anti inflammatory; Opioid; 2 Adrenergic

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CLONIDINE; CODEINE; DEXTROMETHORPHAN; FENTANYL; GABAPENTIN; HYDROMORPHONE; KETAMINE; MEMANTINE; METHADONE; MORPHINE; MORPHINE 6 GLUCURONIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NEUROKININ 1 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE RECEPTOR; OXYCODONE; OXYMORPHONE; PREGABALIN; TIZANIDINE;

CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DRUG BIOAVAILABILITY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG METABOLISM; DRUG TRANSPORT; DRUG WITHDRAWAL; HUMAN; LIVER METABOLISM; NEUROPATHIC PAIN; NONHUMAN; OUTCOMES RESEARCH; PAIN; PHARMACOGENETICS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; VOMITING;

EID: 14644439235     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpain.2004.05.007     Document Type: Article

References (40)

1. N. Andrews, S. Loomis, R. Blake, L. ferigan, L. Singh, and A.T. McKnight Effect of gabapentin-like compounds on development and maintenance of morphine-induced conditioned place preference Psychopharmacology 157 2001 381 387
2. C.P. Bailey, D. couch, E. Johnson, K. Griffiths, E. Kelly, and G. Henderson m-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine J. Neurosci. 23 2003 10515 10520
3. R. Bell, C. Eccleston, and E. Kalso Ketamine as an adjuvant to opioids for cancer pain.Cochrane Database of Systematic Reviews. (1): CD003351, 2003 J Pain Symptom Manage 26 2003 867 875
4. A. Bisaga, S.D. Comer, A.S. Ward, P. Popik, H.D. Kleber, and M.W. Fischman The NMDA antagonists memantine attenuates the expression of opioid physical dependence in humans Psychopharmacology 157 2001 1 10
5. E.A. Bolan, R.J. Tallarida, and G.W. Pasternak Synergy between μopioid ligands: evidence for functional interactions among μopioid receptor subtypes J. Exp. Pharmacol. Ther. 303 2002 557 562
6. M.S. Cepeda, H. Alvarez, O. Morales, and D.B. Carr Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects Pain 107 2004 41 46
7. F. Cesselin Opioid and anti-opioid peptides Fundam. Clin. Pharmacol. 9 1995 409 433
8. V. Chapman, and A.H. Dickenson The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn Brain Res. 573 1992 321 323
9. M.A. Coudoré-Civiale, C. Courteix, M. Boucher, M. Méen, J. Fialip, and A. Eschalier Potentiation of morphine and clomipramine analgesia by cholecystokinin-B antagonist Cl-988 in diabetic rats Neurosci. Lett. 286 2000 37 40
10. J. Dirks, B.B. Fredensborg, D. Christensen, J.S. Fomsgaard, H. Flyger, and J.B. Dahl A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy Anesthesiology 97 2002 560 564
11. J.C. Eisenach, S. DuPen, M. Dubois, R. Miguel, and D. Allin Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group Pain 61 1995 391 399
12. T.J. Gan, B. Ginsberg, P.S. Glass, J. Fortney, R. Jhaveri, and R. Perno Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate Anesthesiology 87 1997 1075 1081
13. I. Gilron, J. Biederman, K. Jhamandas, and M. Hong Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests Anesthesiology 98 2003 1288 1292
14. S. Grass, O. Hoffmann, X.-.J. Xu, and Z. Wiesenfeld-Hallin N-methyl-d-aspartate receptor antagonists potentiate morphine's effect in the rat Acta Physiol. Scand. 158 1996 269 273
15. L. He, J. Fong, M. von Zastrow, and J.L. Whistler Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization Cell 108 2002 271 282
16. T. Heiskanen, B. Härtel, M.-L. Dahl, T. Seppälä, and E. Kalso Dextromethorphan and morphine in chronic pain Pain 96 2002 261 267
17. O. Hoffmann, and Z. Wiesenfeld-Hallin The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats Neuroreport 5 1994 2565 2568
18. E. Kalso, T. Heiskanen, M. Rantio, P.H. Rosenberg, and A. Vainio Epidural and subcutaneous morphine in the management of cancer pain - a double-blind cross-over study Pain 67 1996 443 449
19. E. Kalso, L. Allan, P.L.I. Dellemijn, C.C. Faura, W.K. Ilias, and T.S. Jensen Recommendation for using opioids in chronic non-cancer pain Eur. J. Pain 7 2003 381 386
20. N. Katz Morphidex (MS:DM) double-blind, multiple-dose studies in chronic pain patients J. Pain Symptom Manage. 19 2000 S37 S41
21. J.M. Lashbrook, M.H. Ossipov, J.C. Hunter, R.B. Raffa, R.J. Tallarida, and F. Porreca Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats Pain 82 1999 65 72
22. R. Maldonado, D. Girdlestone, and B.P. Roques RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats Neurosci Lett 156 1993 135 140
23. A.B. Malmberg, and T.L. Yaksh Spinal actions of non-steroidal anti-inflammatory drugs: evidence for central role for prostanoids in nociceptive processing Progr. Pharmacol. Clin. Pharmacol. 10 1993 91 110
24. E. Matthews, and A.H. Dickenson A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy Anesthesiology 96 2002 633 640
25. W. Meissner, U. Schmidt, M. Hartmann, R. Kath, and K. Reinhart Oral naloxone reverses opioid-associated constipation Pain 84 2000 105 109
26. S. Mercadante, A. Casuccio, and F. Fulfaro Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study J. Clin. Oncol. 19 2001 2898 2904
27. Nandi R, Fitzgerald M. Opioid analgesia in the newborn. Eur J Pain 2004 [in press]
28. K. Perttunen, E. Kalso, J. Heinonen, and J. Salo Diclofenac in postthoracotomy pain British Journal of Anaesthesia 68 1992 474 480
29. K.J. Powell, A. Hosokawa, A. Bell, M. Sutak, B. Milne, and R. Quiron comparative effects of cyclo-oxygenase and nitric oxid synthase inhibition on the development and reversal of spinal opioid tolerance Br. J. Pharmacol. 127 1999 631 644
30. K.J. Powell, R. Quirion, and K. Jhamandas Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons Eur. J. Neurosci. 18 2003 1572 1583
31. K. Ranga, and R. Krishnan Clinical experience with substance P receptor (NK1) antagonists in depression J. Clin. Psychiatry 63 suppl 11 2002 25 29
32. S.M. Stahl The ups and downs of novel antiemetic drugs, part 1: substance P, 5-HT, and the neuropharmacology of vomiting J. Clin. Psychiatry 64 2003 498 499
33. Stamer UM, Bayerer B, Stüber F. Genetics and variability in opioid response. Eur J Pain 2004 [in press]
34. J. Stephenson Methylnaltrexone reverses opioid-induced constipation Lancet Oncology 3 2002 202
35. 2 adrenergic antinociception in the rat spinal cord Neurosci. Lett. 139 1992 65 68
36. T. Trang, M. Sutal, R. Quirion, and K. Jhamandas The role of spinal neuropeptides and prostaglandins in opioid physical dependence Br. J. Pharmacol. 136 2002 37 48
37. K.A. Trujillo, and H. Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science 251 1991 85 87
38. X.-.J. Xu, M.J.C. Puke, and V.M.K. Verge Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain Neurosci. Lett. 152 1993 129 132
39. G.C. Yeh, P.L. Tao, J.Y. Chen, M.C. Lai, F.S. Gao, and C.L. Hu Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine Eur. J. Pharmacol. 453 2002 197 202
40. H. Zhu, S. Jenab, K.L. Jones, and C.E. Inturrisi The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat Brain Research: Development Brain Research 142 2003 209 213